RDHL | Redhill Biopharma Ltd.
Industry: Drug Manufacturers—Specialty & Generic Quick infos Trade prices Volume: Market Cap: 325.83M Prev closed: 8.4 Open: 8.24 High: 8.77 Low: 8.2 52 week low: 3.26 52 week high: 11.35 Dividends: No Dividends Next ER: November 12, 2020 Before Market Opens
Company Profile RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a specialty biopharmaceutical company primarily focused on development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases.
Earnings History Date EPS / Forecast Revenue / Forecast November 12, 2020 -0.05 / -0.2720.94M / 25.36MAugust 13, 2020 -0.4 / -0.1420.9M / 22.99MMay 27, 2020 -0.5 / -0.691.06M / 4.38MMarch 4, 2020 -0.33 / -0.321.6M / 1.59MBeat! November 19, 2019 -0.3 / -0.321.4M / 1.79Mview more
Historical Data Date Price Open High Low Vol Change ER Jan 11, 2021 8.71 8.35 8.76
8.32
206.06K 3.69% Jan 8, 2021 8.40 8.52 8.65
8.12
181.28K -2.21% Jan 7, 2021 8.59 8.37 8.66
8.19
225.88K 5.01% Jan 6, 2021 8.18 8.50 8.50
8.09
226.65K 0% Jan 5, 2021 8.18 8.27 8.28
8.03
192.89K 0.12% Jan 4, 2021 8.17 8.35 8.46
8.03
228.75K 1.11% Dec 31, 2020 8.08 8.64 9.32
8.02
840.84K -5.61% Dec 30, 2020 8.56 8.92 9.02
8.45
208.67K -4.46% Dec 29, 2020 8.96 9.56 9.73
8.75
296.62K -5.98% Dec 28, 2020 9.53 9.60 9.72
9.47
143.76K 2.25% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2009 Employees:155 News
RedHill Biopharma Provides Q2/2020 Financial Results and Operational Highlights finance.yahoo.com Aug 14, 2020 7:00 am RedHill Q2 revenue growth spikes on Movantik sales seekingalpha.com Aug 13, 2020 7:19 pm RedHill EPS beats by $0.03, misses on revenue seekingalpha.com Aug 13, 2020 7:05 pm RedHill Biopharma (RDHL) Q2 2020 Earnings Call Transcript fool.com Aug 13, 2020 7:00 pm RedHill teams up with Cosmo Pharma to advance two products seekingalpha.com Aug 13, 2020 6:51 pm
Recap: Redhill Biopharma Q2 Earnings finance.yahoo.com Aug 13, 2020 7:17 am
RedHill Biopharma and Cosmo Pharmaceuticals to Expand Strategic Partnership with Exclusive Licensing Agreement and Manufacturing Agreement for Multiple Products finance.yahoo.com Aug 13, 2020 6:10 am Raleigh pharma to have second drug tested for potential COVID-19 treatment bizjournals.com Aug 12, 2020 7:34 am
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing finance.yahoo.com Aug 12, 2020 8:35 am
Recap: Redhill Biopharma Q1 Earnings finance.yahoo.com Aug 12, 2020 7:23 am
RedHill Biopharma to Focus Commercial Efforts on Talicia® and Aemcolo®; Discontinuing Promotion of Legacy Products finance.yahoo.com Aug 12, 2020 7:15 am
RedHill Biopharma Provides Initial Update from its Opaganib COVID-19 Compassionate Use Program in Israel finance.yahoo.com Aug 12, 2020 7:00 am
RedHill Biopharma Ltd. to Host Earnings Call finance.yahoo.com Aug 12, 2020 6:30 am
U.S. FDA approves RedHill's H. pylori infection treatment finance.yahoo.com Aug 12, 2020 6:14 am
RedHill Biopharma Announces First COVID-19 Patient Treated with Opaganib in Israel Under Compassionate Use finance.yahoo.com Aug 12, 2020 6:05 am
RedHill Biopharma Acquires Rights to Movantik® from AstraZeneca finance.yahoo.com Aug 12, 2020 2:00 am
RedHill Biopharmas Phase 2/3 COVID-19 Study Approved in Mexico finance.yahoo.com Aug 11, 2020 7:00 pm
RedHill Biopharma Announces New Agreement with Daiichi Sankyo for Movantik® finance.yahoo.com Aug 9, 2020 7:00 am
RedHill Biopharma to Host Second Quarter Financial Results and Business Highlights Conference Call and Webcast on August 13, 2020 finance.yahoo.com Aug 7, 2020 11:25 am RedHill to launch COVID-19 study in Mexico seekingalpha.com Aug 6, 2020 9:21 pm This company doesn't provide a dividend.
Key Persons Talk about Redhill Biopharma Ltd. below in comments section below. Do you think you'll buy? Do you already have active trades now?
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.